Effects of a Community-based Multicomponent Physical Exercise Program on Physical Function, Frailty, and Sarcopenia in Older Adults From the Municipality of Santoña: a Quasi-experimental Study.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversidad de Granada

About this trial

This study evaluates the effects of a community-based multicomponent exercise program on physical function, frailty, and sarcopenia in older adults living in the municipality of Santoña (Cantabria, Spain). The exercise program is organized and delivered by the Santoña Town Council as part of its public health services for older residents and is not created for research purposes; it will continue regardless of the outcome of this study. Researchers are only evaluating participants who voluntarily agree to be assessed before and after each 36-week cycle of the program, over four consecutive academic years (2026-2030). The main question this study aims to answer is whether continued participation in this real-world, community-based multicomponent exercise program (based on the Vivifrail model) leads to meaningful improvements in physical function, muscle strength, and cardiorespiratory capacity, and helps reverse indicators of frailty and sarcopenia in independent, community-dwelling older adults. Participants will complete functional and physical tests, including balance, gait speed, chair-stand performance, handgrip strength, and a 6-minute walk test, at the start and end of each 36-week exercise cycle. No blood or biological samples will be collected.

Eligibility criteria

Qualifiers

Age 65 years or older

Independent, community-dwelling (not institutionalized)

Barthel Index score ≥ 90 points (no significant disability)

Timed Up and Go (TUG) test ≥ 10 seconds

Disqualifiers

Terminal illness

Residing in a nursing home

Diagnosed with, or under investigation for, moderate to severe cognitive impairment

Unstable cardiovascular disease

Trial design

Treatments tested in this trial

  • Multicomponent Exercise Program (Vivifrail-based)

Treatment groups

300 Participants
are divided into 1 treatment group

Sponsors and collaborators